BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10395990)

  • 1. Risk factors associated with hypertensive nephrosclerosis.
    Bleyer AJ; Appel RG
    Nephron; 1999; 82(3):193-8. PubMed ID: 10395990
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors regulating the progression of hypertensive nephrosclerosis.
    Razzaque MS; Azouz A; Shinagawa T; Taguchi T
    Contrib Nephrol; 2003; 139():173-86. PubMed ID: 12854325
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.
    Marín R; Gorostidi M; Fernández-Vega F; Alvarez-Navascués R
    Kidney Int Suppl; 2005 Dec; (99):S52-6. PubMed ID: 16336577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'.
    Kincaid-Smith P
    J Hypertens; 2004 Jun; 22(6):1051-5. PubMed ID: 15167435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertensive nephrosclerosis.
    Luke RG
    Kidney Int; 2006 Oct; 70(7):1383; author reply 1383-4. PubMed ID: 16988752
    [No Abstract]   [Full Text] [Related]  

  • 6. [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits].
    Boulahrouz R; Autuly V; Charasse C; Le Cacheux P; Ang KS; Ramee MP; Simon P
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1065-8. PubMed ID: 8949380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-nephron pressures, flows, and resistances in hypertensive kidneys with nephrosclerosis.
    Azar S; Johnson MA; Hertel B; Tobian L
    Kidney Int; 1977 Jul; 12(1):28-40. PubMed ID: 894914
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular nephropathies and nephrosclerosis: epidemiology and pathophysiology.
    Meyrier A; Simon P; Montseny JJ; Eladari D; Charasse C
    Adv Nephrol Necker Hosp; 1997; 26():207-45. PubMed ID: 8922135
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P; Zuccalà A; Gaggi R
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
    Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
    BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephroangiosclerosis or hypertensive nephropathy].
    del Río Vázquez A
    Rev Clin Esp; 1994 Aug; 194(8):620-2. PubMed ID: 7938843
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of nephrosclerosis in separate function tests.
    Berman LB; Vertes V; Cohen SM; Galvin JB
    Arch Intern Med; 1970 May; 125(5):843-9. PubMed ID: 5444314
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nephrosclerosis. The Cinderella of chronic kidney disease].
    Martín R; Gorostidi M; Díez Ojea B
    Nefrologia; 2010; 30(3):275-9. PubMed ID: 20514095
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteinuria in benign nephrosclerosis.
    Morduchowicz G; Boner G; Ben-Bassat M; Rosenfeld JB
    Arch Intern Med; 1986 Aug; 146(8):1513-6. PubMed ID: 3729631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal renin in experimental nephrosclerosis.
    Mersereau WA; Moore S; Fernandez H
    J Pathol; 1972 Dec; 108(4):319-27. PubMed ID: 4349555
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic/secreting and apoptotic phenotypes in renal biopsy tissues from hypertensive nephrosclerosis patients.
    Kimura N; Yonemoto S; Machiguchi T; Li X; Kimura H; Yoshida H
    Hypertens Res; 2006 Aug; 29(8):573-80. PubMed ID: 17137212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal blood flow in hypertension and in renal disease.
    Hollenberg NK
    Prog Nucl Med; 1972; 2():200-34. PubMed ID: 4569509
    [No Abstract]   [Full Text] [Related]  

  • 19. The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view.
    Zucchelli P; Zuccalà A
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):87-91. PubMed ID: 8494026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is nephroangiosclerosis a hypertension-induced nephropathy?
    Zuccalà A; Zucchelli P
    Contrib Nephrol; 1996; 119():110-4. PubMed ID: 8783600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.